139 related articles for article (PubMed ID: 31309656)
1. Screening and characterization of a novel high-efficiency tumor-homing cell-penetrating peptide from the buffalo cathelicidin family.
Xu YY; Cao XW; Fu LY; Zhang TZ; Wang FJ; Zhao J
J Pept Sci; 2019 Sep; 25(9):e3201. PubMed ID: 31309656
[TBL] [Abstract][Full Text] [Related]
2. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity.
Gronewold A; Horn M; Ranđelović I; Tóvári J; Muñoz Vázquez S; Schomäcker K; Neundorf I
ChemMedChem; 2017 Jan; 12(1):42-49. PubMed ID: 27860402
[TBL] [Abstract][Full Text] [Related]
4. Penetratin-mediated delivery enhances the antitumor activity of the cationic antimicrobial peptide Magainin II.
Liu S; Yang H; Wan L; Cheng J; Lu X
Cancer Biother Radiopharm; 2013 May; 28(4):289-97. PubMed ID: 23286306
[TBL] [Abstract][Full Text] [Related]
5. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
6. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
Lyu L; Huang LQ; Huang T; Xiang W; Yuan JD; Zhang CH
Drug Des Devel Ther; 2018; 12():743-756. PubMed ID: 29670331
[TBL] [Abstract][Full Text] [Related]
7. Effectively enhancing cytotoxic and apoptotic effects of alpha-momorcharin by integrating a heparin-binding peptide.
Tan MJ; Cao XW; Li PF; Zhai YZ; Zhou Y; Liu YJ; Zhao J; Wang FJ
Biotechnol Appl Biochem; 2017 Nov; 64(6):918-926. PubMed ID: 28090686
[TBL] [Abstract][Full Text] [Related]
8. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
9. Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability.
Deng X; Qiu Q; Ma K; Wang X; Huang W; Qian H
Org Biomol Chem; 2015 Jul; 13(28):7673-80. PubMed ID: 26083110
[TBL] [Abstract][Full Text] [Related]
10. Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide.
Sioud M; Mobergslien A
Biochem Pharmacol; 2012 Nov; 84(9):1123-32. PubMed ID: 22922046
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
12. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
13. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
14. Molecular tumor targeting of gelonin by fusion with F3 peptide.
Ham SH; Min KA; Shin MC
Acta Pharmacol Sin; 2017 Jun; 38(6):897-906. PubMed ID: 28414205
[TBL] [Abstract][Full Text] [Related]
15. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
Jana A; Narula P; Chugh A; Kulshreshtha R
Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides.
Vale N; Ferreira A; Fernandes I; Alves C; Araújo MJ; Mateus N; Gomes P
Bioorg Med Chem Lett; 2017 Jul; 27(13):2898-2901. PubMed ID: 28495087
[TBL] [Abstract][Full Text] [Related]
17. [Enhancement of cytotoxicity of cantionic antimicrobial peptide in tumor cells by conjugation to cell-penetrating peptide].
Liu S; Yang H; Cai H; Wan L; Lu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb; 28(1):110-4. PubMed ID: 21485195
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.
Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H
Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093
[TBL] [Abstract][Full Text] [Related]
19. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
20. Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.
Tzitzilis A; Boura-Theodorou A; Michail V; Papadopoulos S; Krikorian D; Lekka ME; Koukkou AI; Sakarellos-Daitsiotis M; Panou-Pomonis E
J Pept Sci; 2020 Jul; 26(7):e3254. PubMed ID: 32567085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]